Analyst Ratings for aTyr Pharma (LIFE)

LIFE Rating Summary

LIFE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on LIFE
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $4.00 (+33.3%) * Over Last 12-Mos
Rating Score: 0 / 10   Percentile Rank: 0%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
12/13/2016 JPMorgan Downgrade Neutral
(Overweight)
N/A
(10.00)
3.65 3.00 -17.81% Details
4/12/2016 BMO Capital
» Updated 12/13/2016
New Coverage Market Perform
(N/A)
4.00
(8.00)
3.62 3.00 -17.13% Details
Like LIFE Ratings? Also take a look at PIP, OSG, PJT, PPHM

LIFE Ratings News